Cntx earnings
WebJul 1, 2024 · new earnings signals; insider trading; insider tracker; estimize forecasts; risk factors ... amr opof rna bzfd weth lscc lwlg arnc dvax atlo ke dg adom trup geo lask amrs aspu cyrx pkg alv nie cvs stel abeo strs jewl awh seel smap lind mtex pnr cntx mtz silk rvmd aht inod trmb vcnx forg gbny lrfc blco clsk tyme tech snx drna zts ambc reemf dtgi ... WebMar 24, 2024 · Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) – Equities researchers at HC Wainwright issued their FY2027 earnings per share estimates for shares of Context Therapeutics in a research report issued on Thursday, March 23rd.HC Wainwright analyst E. Bodnar anticipates that the company will post earnings per share …
Cntx earnings
Did you know?
Web2 hours ago · Context Therapeutics Inc. CNTX is a biopharmaceutical company committed to advancing medicines for solid tumors by harnessing novel and innovative treatment targets such as Claudin 6 (CLDN6). A ... WebApr 6, 2024 · Their CNTX share price forecasts range from $4.00 to $4.00. On average, they predict the company's share price to reach $4.00 in the next twelve months. This …
WebMar 24, 2024 · Detailed statistics for Context Therapeutics Inc. (CNTX) stock, including valuation metrics, financial numbers, share information and more. ... Estimated Earnings Date May 10, 2024: Ex-Dividend Date n/a: Share Statistics. CNTX has 15.97 million shares outstanding. The number of shares has increased by 463.44% in one year. WebApr 10, 2024 · Get a real-time Context Therapeutics Inc. (CNTX) stock price quote with breaking news, financials, statistics, charts and more. ... Earnings Date: May 10, 2024: About CNTX. Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead …
WebApr 6, 2024 · Company Summary. Context Therapeutics Inc. is a women's oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and ...
WebIn depth view into CNTX (Context Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Context Therapeutics Inc (CNTX) 0.5622 -0.02 ( -3.40% ) USD NASDAQ Mar 31, 16:00
WebTable displays both upcoming quarterly earnings dates and historical release dates. ... (CNTX). Stocks Features Premarket Trading After Hours Trading Market Movers 52-Week Highs & Lows Stock Order Imbalance Unusual Stock … hosakottiWebMar 22, 2024 · Context Therapeutics (CNTX) Earnings Date & Reports 30 Followers Portfolio Earnings Data Report Date Mar 22, 2024 Not Confirmed Period Ending 2024 … hosa missionWebA number of insiders bought Context Therapeutics Inc. (NASDAQ:CNTX) stock last year, which is great news for shareholders. Generally, when a single insider buys stock, it is … hosalliWebMar 24, 2024 · Context Therapeutics Inc CNTX:NASDAQ EXPORT WATCHLIST + RT Quote Last NASDAQ LS, VOL From CTA USD After Hours: Last 03/24/23 EDT 0.62 … hosaku restaurantWebCNTX Earnings Forecast. Next quarter’s earnings estimate for CNTX is -$0.29 with a range of -$0.33 to -$0.26. The previous quarter’s EPS was -$0.24. CNTX beat its EPS … ho saltato 2 pilloleWebMar 23, 2024 · The following information was filed by Context Therapeutics Inc. (CNTX) on Wednesday, March 23, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the … hosa mcneilWebOn Invalid Date, . Context Therapeutics (NASDAQ: CNTX) reported Q4 2024 earnings per share (EPS) of -$0.22, up 101.29% year over year. Total Context Therapeutics earnings for the quarter were -$3.56 million.In the same quarter last year, Context Therapeutics's earnings per share (EPS) was $17.05. hosa lake